Biopharma | May 13, 2026
Eli Lilly launches Lormalzi for early Alzheimer’s treatment in India
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Paves way for CNS cancer test rollout
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
Women’s wellness initiative promoted preventive healthcare, fitness, and self-care awareness across the Mira Bhayandar community
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
The public health summit in Addis Ababa will bring together policymakers, scientists, healthcare leaders, and global partners
Subscribe To Our Newsletter & Stay Updated
